vs
Side-by-side financial comparison of DT Cloud Star Acquisition Corp (DTSQ) and Prime Medicine, Inc. (PRME). Click either name above to swap in a different company.
Prime Medicine, Inc. is the larger business by last-quarter revenue ($838.0K vs $452.4K, roughly 1.9× DT Cloud Star Acquisition Corp). DT Cloud Star Acquisition Corp runs the higher net margin — 63.7% vs -5498.7%, a 5562.3% gap on every dollar of revenue.
DT Cloud Star Acquisition Corp is a special purpose acquisition company dedicated to pursuing business combinations with high-growth enterprises operating in cloud technology, enterprise software and digital services sectors, primarily targeting innovative players across the Asia-Pacific region.
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
DTSQ vs PRME — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $452.4K | $838.0K |
| Net Profit | $288.0K | $-46.1M |
| Gross Margin | — | — |
| Operating Margin | -36.4% | -5800.5% |
| Net Margin | 63.7% | -5498.7% |
| Revenue YoY | — | -61.6% |
| Net Profit YoY | — | -9.0% |
| EPS (diluted) | — | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $452.4K | $838.0K | ||
| Q3 25 | $751.5K | $1.2M | ||
| Q2 25 | $742.2K | $1.1M | ||
| Q1 25 | $737.7K | $1.5M | ||
| Q4 24 | — | $2.2M | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $591.0K | ||
| Q4 23 | — | $0 |
| Q4 25 | $288.0K | $-46.1M | ||
| Q3 25 | $583.0K | $-50.6M | ||
| Q2 25 | $631.5K | $-52.6M | ||
| Q1 25 | $630.3K | $-51.9M | ||
| Q4 24 | — | $-42.3M | ||
| Q2 24 | — | $-55.3M | ||
| Q1 24 | — | $-45.8M | ||
| Q4 23 | — | $-65.6M |
| Q4 25 | -36.4% | -5800.5% | ||
| Q3 25 | -22.5% | -4406.0% | ||
| Q2 25 | -15.2% | -4787.2% | ||
| Q1 25 | -15.0% | -3603.3% | ||
| Q4 24 | — | -2025.7% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -8179.5% | ||
| Q4 23 | — | — |
| Q4 25 | 63.7% | -5498.7% | ||
| Q3 25 | 77.6% | -4129.1% | ||
| Q2 25 | 85.1% | -4716.7% | ||
| Q1 25 | 85.4% | -3568.8% | ||
| Q4 24 | — | -1936.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -7743.0% | ||
| Q4 23 | — | — |
| Q4 25 | — | $-0.22 | ||
| Q3 25 | — | $-0.32 | ||
| Q2 25 | — | $-0.41 | ||
| Q1 25 | — | $-0.40 | ||
| Q4 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.46 | ||
| Q1 24 | — | $-0.44 | ||
| Q4 23 | — | $-0.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $461 | $63.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-1.1M | $120.9M |
| Total Assets | $18.0M | $342.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $461 | $63.0M | ||
| Q3 25 | $20.1K | $71.4M | ||
| Q2 25 | $126.1K | $53.8M | ||
| Q1 25 | $271.5K | $91.9M | ||
| Q4 24 | — | $182.5M | ||
| Q2 24 | — | $55.6M | ||
| Q1 24 | — | $94.2M | ||
| Q4 23 | — | $41.6M |
| Q4 25 | $-1.1M | $120.9M | ||
| Q3 25 | $-736.8K | $161.8M | ||
| Q2 25 | $-568.4K | $60.9M | ||
| Q1 25 | $-457.7K | $106.9M | ||
| Q4 24 | — | $153.1M | ||
| Q2 24 | — | $196.6M | ||
| Q1 24 | — | $243.8M | ||
| Q4 23 | — | $133.1M |
| Q4 25 | $18.0M | $342.7M | ||
| Q3 25 | $72.7M | $385.0M | ||
| Q2 25 | $72.1M | $279.0M | ||
| Q1 25 | $71.6M | $328.2M | ||
| Q4 24 | — | $297.5M | ||
| Q2 24 | — | $259.7M | ||
| Q1 24 | — | $311.4M | ||
| Q4 23 | — | $193.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-411.0K | $-37.3M |
| Free Cash FlowOCF − Capex | — | $-37.5M |
| FCF MarginFCF / Revenue | — | -4480.4% |
| Capex IntensityCapex / Revenue | — | 34.6% |
| Cash ConversionOCF / Net Profit | -1.43× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-167.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-411.0K | $-37.3M | ||
| Q3 25 | $-105.9K | $-35.0M | ||
| Q2 25 | $-145.5K | $-41.4M | ||
| Q1 25 | $-139.9K | $-48.9M | ||
| Q4 24 | — | $16.2M | ||
| Q2 24 | — | $-45.5M | ||
| Q1 24 | — | $-67.7M | ||
| Q4 23 | — | $-43.9M |
| Q4 25 | — | $-37.5M | ||
| Q3 25 | — | $-35.3M | ||
| Q2 25 | — | $-43.0M | ||
| Q1 25 | — | $-51.3M | ||
| Q4 24 | — | $14.5M | ||
| Q2 24 | — | $-47.4M | ||
| Q1 24 | — | $-70.0M | ||
| Q4 23 | — | $-45.7M |
| Q4 25 | — | -4480.4% | ||
| Q3 25 | — | -2880.5% | ||
| Q2 25 | — | -3855.1% | ||
| Q1 25 | — | -3526.8% | ||
| Q4 24 | — | 662.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -11849.6% | ||
| Q4 23 | — | — |
| Q4 25 | — | 34.6% | ||
| Q3 25 | — | 20.2% | ||
| Q2 25 | — | 141.0% | ||
| Q1 25 | — | 166.6% | ||
| Q4 24 | — | 82.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 393.2% | ||
| Q4 23 | — | — |
| Q4 25 | -1.43× | — | ||
| Q3 25 | -0.18× | — | ||
| Q2 25 | -0.23× | — | ||
| Q1 25 | -0.22× | — | ||
| Q4 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
